Does Boron Help With Skin Cancer Response?
BNCT showed a 70% response rate in patients with scalp angiosarcoma and malignant melanoma.
Weak EvidenceEvidence Summary
BNCT showed a 70% response rate in patients with scalp angiosarcoma and malignant melanoma.
Effective Dose
Medical procedure — not a supplement dose
Supporting Studies
Every PMID below is a real paper indexed in PubMed. Click any to read the abstract or full text. These are the specific studies HypeCheck cited to support this claim — verify the chain yourself.